Bernstein reaffirms buy rating for UnitedHealth

Bernstein analyst Lance Wilkes has reaffirmed his buy rating for UnitedHealth (UNH.US) while maintaining a target price of $512. This latest recommendation comes as part of a broader analysis of the healthcare giant's performance and future prospects.

According to data from TipRanks, Wilkes has a success rate of 51.0% and an average return of 9.0% over the past year. These metrics reflect his performance based on TipRanks' virtual portfolio, which tracks the outcomes of his ratings.

TipRanks, an independent third-party platform, evaluates analysts based on their success rate and average return. Wilkes' ranking is determined by his track record, which includes both successful and unsuccessful ratings over the specified period.

The information provided by TipRanks is intended for informational purposes only and does not constitute an investment recommendation. It serves as a tool for investors to gauge the performance of financial analysts.